Assessing the immunogenic and protective potential of different viral vector regimes, in the mouse model of tuberculosis infection

Assessing the immunogenic and protective potential of different viral vector regimes, in the mouse model of tuberculosis infection

Bibliografische gegevens
Hoofdauteurs:	Stylianou, E, Betts, G, Dicks, M, Griffiths, K, Poyntz, H, Mcshane, H
Formaat:	Conference item
Gepubliceerd in:	2011

Gelijkaardige items

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection
door: Betts, G, et al.
Gepubliceerd in: (2012)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
door: Griffiths, K, et al.
Gepubliceerd in: (2013)

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.
door: Gareth Betts, et al.
Gepubliceerd in: (2012-01-01)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
door: Griffiths, K, et al.
Gepubliceerd in: (2011)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
door: Stylianou, E, et al.
Gepubliceerd in: (2015)

Evaluation of immunological mechanisms induced by Mycobacterium avium exposure and the effect upon pre-existing BCG immunity
door: Poyntz, H, et al.
Gepubliceerd in: (2011)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
door: Poyntz, H, et al.
Gepubliceerd in: (2014)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
door: Marsay, L, et al.
Gepubliceerd in: (2013)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis
door: Poyntz, H, et al.
Gepubliceerd in: (2014)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
door: Marsay, L, et al.
Gepubliceerd in: (2013)

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis
door: Christopher J. De Voss, et al.
Gepubliceerd in: (2025-02-01)

Viral vector delivery of Env trimer immunogens
door: Parks CL, et al.
Gepubliceerd in: (2012-09-01)

Uncovering the mechanisms of adenovirus vector immunogenicity
door: Dicks, M, et al.
Gepubliceerd in: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
door: Meyer, J, et al.
Gepubliceerd in: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
door: Meyer, J, et al.
Gepubliceerd in: (2013)

Viral vectors as vaccine platforms: from immunogenicity to impact
door: Ewer (nee Russell), K, et al.
Gepubliceerd in: (2016)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
door: Biswas, S, et al.
Gepubliceerd in: (2011)

Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
door: Poyntz, HC
Gepubliceerd in: (2012)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
door: Mcshane, H, et al.
Gepubliceerd in: (2001)

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.
door: Rowland, R, et al.
Gepubliceerd in: (2013)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
door: Sumi Biswas, et al.
Gepubliceerd in: (2011-01-01)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
door: Dicks, M, et al.
Gepubliceerd in: (2011)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
door: Sushmita Kumari, et al.
Gepubliceerd in: (2022-08-01)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-riming and boosting with adenovirus or protein based vaccines
door: Dean, G, et al.
Gepubliceerd in: (2014)

Assessment of immunogenicity and neutralisation efficacy of viral-vectored vaccines against Chikungunya virus
door: López-Camacho, C, et al.
Gepubliceerd in: (2019)

Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19
door: Aiquan Chang, et al.
Gepubliceerd in: (2022-02-01)

Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus
door: César López-Camacho, et al.
Gepubliceerd in: (2019-04-01)

Protection by Persuasion: International Cooperation in the Refugee Regime
door: Betts, A
Gepubliceerd in: (2010)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
door: Dean, G, et al.
Gepubliceerd in: (2014)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
door: Dicks, M, et al.
Gepubliceerd in: (2012)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
door: Sander, C, et al.
Gepubliceerd in: (2009)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
door: Vordermeier, H, et al.
Gepubliceerd in: (2009)

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques.
door: White, A, et al.
Gepubliceerd in: (2013)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
door: Vordermeier, H, et al.
Gepubliceerd in: (2011)

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
door: Goonetilleke, N, et al.
Gepubliceerd in: (2003)

Immunogenicity and protective efficacy of inactivated coxsackievirus B4 viral particles
door: Tingfeng Wang, et al.
Gepubliceerd in: (2024-12-01)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
door: Stylianou, E, et al.
Gepubliceerd in: (2019)

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
door: Dulce Mata-Espinosa, et al.
Gepubliceerd in: (2023-10-01)

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
door: Brookes, R, et al.
Gepubliceerd in: (2008)

Evaluation of Duration of Immunogenicity and Protective Efficacy of Improved Influenza Viral Vector–Based Brucella abortus Vaccine Against Brucella melitensis Infection in Sheep and Goats
door: Aigerim Mailybayeva, et al.
Gepubliceerd in: (2020-02-01)